Luxembourgish Multidisciplinary Immunotoxicity Board

Questions handled 

  1. Diagnosis and management of severe immune related adverse events
  2. Starting immunotherapy in ‘dysimmune’ patients
      • transplant patients
      • patients with chronic (viral) infections
      • patients with autoimmune disorders
      • immunosuppressed patients
      • rechallenge after irAE
      • other

3. Safety of immunosuppression in a patient with cancer

4. Strategies for infection prevention and control in immunotherapy-treated patients



Monthly virtual meeting via Teams

- onco/hematologists, organspecialists and interested healthcare professionals

- Timing: 1st Monday of each month 16:30-17:30

- if you are unable to attend, the case can still be discussed with a written recommendation provided